Cingulate Inc.
CINGNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $61.84M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.16$11.89
- Volume (live)
- -
- Avg. volume (3M)
- 96.82K
Cingulate (CING) Stock Price & Financial Analysis
Cingulate Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.60 - $4.82 |
|---|---|
| 52-Week High | $11.89 |
| 52-Week Low | $3.16 |
| Open | $4.60 |
| Volume (last close) | 77.95K |
| Average Volume (3M) | 96.82K |
| 50-Day MA | $5.05 |
|---|---|
| 200-Day MA | $5.43 |
| 1-Year Change | +31.01% |
| Market Cap | 61.84M |
|---|---|
| Shares Outstanding | 13.19M |
| Price to Book (P/B) | 2.64 |
| EV/EBITDA | -1.61 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Cingulate at a Glance
As of the Oct 22, 2026 close, Cingulate (CING) has a market capitalization of $61.84M.
As of its latest reported balance sheet, it holds $28.40M in cash and securities against $6.04M of debt, a net cash position of $22.37M.
Cingulate does not currently pay a dividend.
The share price is up 31.0% over the past year. At $4.69 (the Oct 22, 2026 close) it sits within its 52-week range of $3.16 to $11.89, below its 200-day moving average of $5.43.
Frequently Asked Questions About Cingulate
What is the current stock price for CING?
As of the Oct 22, 2026 close, CING stock trades at $4.69. The 52-week range is $3.16–$11.89, with a day range of $4.60–$4.82.
What is the P/E ratio for CING?
The P/E ratio (Price-to-Earnings) for CING is shown in the Key Statistics section. This valuation metric helps compare Cingulate Inc. to industry peers.
Does CING pay dividends?
Cingulate does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CING?
Analyst ratings and recommendations for CING are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CING?
As of the Oct 22, 2026 close, Cingulate's market capitalization is $61.8M, classifying it as a micro-cap company. Cingulate operates in the Healthcare sector within the Biotechnology industry.